latest news: Pharmaceuticals
Showing 10 of 74 Articles:
-
Phytecs preclinical data indicates its fluorinated CBD exhibits greater potency than CBD in models of psychiatric disorders
Phytecs is expanding its preclinical research program on its novel fluorinated cannabidiol, HUF-101, along with its family of related drug molecules developed by noted medicinal chemist and Phytecs Director of Global Research, Prof. Raphael Mechoulam of The Hebrew University of Jerusalem. A new preclinical study found HUF-101 effective in mice models predictive of anxiolytic, antidepressant, […]
International Pharmaceuticals -
FDA to Require Pharma to Update Fluoroquinolone Labels
The FDA will now require pharmaceuticals to update drug labels and medication guides for all antibacterial drugs containing Fluoroquinolone. The labels and guides must reflect the findings of ongoing studies that led to an FDA warning issued earlier this year. The FDA cautioned practitioners to prescribe fluoroquinolones only when no alternative treatments are an option. […]
United States, National USA Pharmaceuticals -
FDA updates warnings for fluoroquinolone antibiotics
Limits use for acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis and uncomplicated urinary tract infections The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients […]
United States, National USA Pharmaceuticals -
FDA updates warnings for fluoroquinolone antibiotics
Limits use for acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis and uncomplicated urinary tract infections The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients […]
United States, National USA Pharmaceuticals -
Prescription Drugs That Contain Fluoride
Fluoridated drugs may be causing more damage than good in the long run. Fluoride is a known toxin that negatively impacts the brain, the heart and has caused death in test animals. “Including fluorine atoms in medicines can have a variety of dramatic effects on the molecules’ properties, perhaps making them more selective, increasing their […]
Pharmaceuticals -
Fluoride Action Network files Citizen’s Petition to FDA to remove fluoride supplements from market
LOS ANGELES, – The U.S. Food & Drug Administration has issued a “Warning Letter” that orders a manufacturer of fluoride drops and tablets to “immediately” discontinue marketing these products because FDA has never approved them as safe and effective. On Wednesday, the Fluoride Action Network joined with The International Academy of Oral Medicine & Toxicology […]
United States, National USA Pharmaceuticals -
Petition Calls on FDA to Pull All Fluoride Supplements From the Market
The Fluoride Action Network (FAN) and the International Academy of Oral Medicine & Toxicology (IAOMT) are calling on the US Food & Drug Administration (FDA) to expedite the removal from the market all unapproved, unsafe, unnecessary and ineffective sodium fluoride-containing drops, tablets and lozenges sold for the intended purpose of preventing tooth decay. The petition, […]
United States, National USA Pharmaceuticals -
Petition Asks FDA to Remove All Unapproved Fluoride Supplements from Market
LOS ANGELES – PRNewswire-USNewswire/ — The U.S. Food & Drug Administration (FDA) has issued a “Warning Letter” that orders a manufacturer of fluoride drops and tablets to “immediately” discontinue marketing these products because FDA has never approved them as safe and effective. Now the Fluoride Action Network (FAN) has joined with The International Academy of Oral […]
United States, Fluoride Action Network Press Release United States Pharmaceuticals -
Qualitest: Michigan to get nearly $700K over false vitamin claims
A national drug company will pay almost $700,000 to the state of Michigan as part of a multi-million dollar settlement stemming from a lawsuit alleging the company falsely labeled a dental health multivitamin sold nationwide. Qualitest Pharmaceuticals Inc. marketed multivitamin tablets that contained less than 50 percent of the fluoride claimed on the labels, Michigan […]
United States, Michigan Pharmaceuticals -
Qualitest: New Jersey to receive $2.7 million in multistate settlement
New Jersey will receive $2.7 million as part of a global settlement with an Alabama pharmaceutical company for allegedly mislabeling its multivitamin tablets to indicate the products had more fluoride than they actually did, state officials said Tuesday. Qualitest Pharmaceuticals will pay 47 participating states, including New Jersey, and the federal government a total of […]
United States, New Jersey Pharmaceuticals